References
- Exelon. Summary of Product Characteristic. www.emea.eu.int Accessed October 25, 2004.
- Rogawski M A. What is the rationale for new treatment strategies in Alzheimer's disease?CNS Spectr 2004; 9(7):6–12, [PUBMED], [INFOTRIEVE], [CSA]
- Kelly C A, Dhaun N, Laing W J, Strachan F E, Good A M, Bateman D N. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol, Clin Toxicol 2004; 42(1):67–71, [CROSSREF], [CSA]
- Ragoucy-Sengler C, Tracqui A, Chavonnet A, Daijardin J B, Simonetti M, Kintz P, Pileire B. Aldicarb poisoning. Hum Exp Toxicol 2000; 19(12):657–662, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lifshitz M, Rotenberg M, Sofer S, Tamir T, Shahak E, Almog S. Carbamate poisoning and oxime treatment in children: a clinical and laboratory study. Pediatrics 1994; 94:652–655, [CSA]